Global prevalence of hydrocele in infants and children: a systematic review and meta-analysis

Nader Salari1, Mahan Beiromvand2, Reza Abdollahi3

  • 1Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.

BMC Pediatrics
|February 22, 2025
PubMed

Insights

Pediatric hydrocele, a common congenital condition in infants, affects 1 in 1000 live births. Early screening and health policies are crucial to address undiagnosed cases in children and prevent long-term consequences.

Area of Science:

  • Pediatric Urology
  • Public Health
  • Epidemiology

Background:

  • Pediatric hydrocele is a common congenital condition in newborns.
  • Untreated cases can lead to permanent adverse effects in adulthood.
  • Understanding global prevalence is vital for health policy development.

Purpose of the Study:

  • To investigate the global prevalence of pediatric hydrocele in infants and children.
  • To provide essential data for health policymakers regarding this condition.

Main Methods:

  • Systematic literature search across multiple databases (PubMed, Scopus, Web of Science, Embase, ScienceDirect, Google Scholar).
  • Keywords: "Prevalence", "Outbreak hydrocele", "Infant", "Child".
  • Meta-analysis using a random-effects model with heterogeneity assessed by the I² index.

Main Results:

  • Global prevalence in infants (1-2 weeks) is 0.001% (1 per 1000 live births) based on 5 studies (70,961 infants).
  • Global prevalence in children (7-12 years) is 0.0034% (3.4 per 1000 children) based on 3 studies (278,597 children).

Conclusions:

  • A significant global prevalence of pediatric hydrocele exists, particularly in infants.
  • Undiagnosed or recurrent cases in children necessitate improved medical screening.
  • Implementation of health policies is recommended to mitigate prevalence and adverse outcomes.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...